Home Page
-
Study uses new tools, machine learning to investigate major cause of blindness in older adults
An international collaboration led by Vanderbilt researchers has identified a key component in lesions associated with age-related macular degeneration (AMD), a leading cause of blindness in older adults. Read MoreDec. 20, 2023
-
Anti-aging researcher Monica Driscoll, Rutgers University, to present Apex Lecture on January 8
Anti-aging researcher and National Academy of Sciences member Monica Driscoll (Rutgers University) to deliver the Vanderbilt Basic Sciences Apex Lecture. Read MoreDec. 14, 2023
-
Quanta Magazine: She Studies How Addiction Hijacks Learning in the Brain
Erin Calipari works to understand how drugs like opioids and cocaine alter learning circuits and neurochemistry in one of the country's epicenters of substance use disorder and addiction. Read MoreDec. 13, 2023
-
Kit Neikirk named Marshall Scholar; will study at University of Edinburgh and University College London
Kit Neikirk, postbaccalaureate research intern in the lab of Antentor O Hinton Jr., has been named a 2024 Marshall Scholar by the British government. As a Marshall Scholar, Neikirk will pursue a master’s in public health and an advanced degree in biomedical imaging at University of Edinburgh and University College London, respectively. Read MoreDec. 12, 2023
-
Experiencing the Neural Symphony Underlying Memory through a Blend of Science and Art
Neuroscientist Saman Abbaspoor in the Hoffman lab won the NIH BRAIN Initiatve's annual Show Us Your BRAINs! Photo and Video contest. The clip shows how “sharp-wave ripples", different layers of neural activity in the hippocampus, are wirelessly recorded to help study memory. Read MoreDec. 11, 2023
-
Colorectal cancer ‘cartography’ reveals an avenue to improved immunotherapy
Second only to lung cancer, colorectal cancer is the nation’s leading cancer killer — accounting for more than 52,000 deaths in the United States each year. Colorectal cancers are divided into two main groups, based on microsatellites, or repeat sections, in their DNA. Read MoreDec. 11, 2023
-
Potential schizophrenia treatment, discovered at Vanderbilt and being developed by Neumora Therapeutics, entering Phase 1 clinical trial
A potential schizophrenia treatment discovered through the Warren Center for Neuroscience Drug Discovery has been cleared by the U.S. Food and Drug Administration for use in phase 1 clinical trials—the third WCNDD therapeutic to reach that benchmark. “Vanderbilt is proud that a discovery by our researchers at the Warren Center… Read MoreDec. 4, 2023
-
Researchers discover key step to kidney fibrosis
Researchers at Vanderbilt University Medical Center for the first time have shown that activation of the epidermal growth factor receptor (EGFR) is essential for the development of kidney fibrosis, tissue scarring following injury that can lead to kidney failure. Their discovery, reported Nov. 14 in the journal Nature Communications,… Read MoreNov. 22, 2023
-
Tiffany Lawrence Givens promoted to assistant dean for administration
Tiffany Lawrence Givens, director of human resources, will become assistant dean for administration on Dec. 1. In this role, she will support Dean John Kuriyan in advancing strategic priorities and provide operational leadership. Read MoreNov. 21, 2023